| Overview |
| bs-3661R-Cy5 |
| HADHSC Polyclonal Antibody, Cy5 Conjugated |
| IF |
| Mouse, Rat |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from mouse HADHSC |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3033 |
| Cytoplasm |
| HAD; HADHSC; HCDH; HHF4; M SCHAD; Medium and short chain L 3 hydroxyacyl coenzyme A dehydrogenase; SCHAD; Short chain 3 hydroxyacyl CoA dehydrogenase mitochondrial. |
| HADHSC functions in the mitochondrial matrix to catalyze the oxidation of straight-chain 3-hydroxyacyl-CoAs as part of the beta-oxidation pathway. Its enzymatic activity is highest with medium-chain-length fatty acids. Mutations in this gene cause one form of familial hyperinsulinemic hypoglycemia. The human genome contains a related pseudogene. |
| Application Dilution |
| IF |
|
Powered by Bioz